Med. praxi. 2019;16(4):254-256 | DOI: 10.36290/med.2019.039

Current options of treating vulvovaginal discomfort

doc. MUDr. Tomáš Fait, Ph.D.
Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha

Vulvovaginal discomfort is a common complaint in gynaecological patients. More frequently, the cause is dysbacteriosis rather
than infection. The condition tends to recur. In addition to anti-infective therapy, restoration of the vaginal milieu with probiotics
is recommended for both treatment and prevention.

Keywords: vulvovaginal discomfort, probiotics, benzydamine

Published: October 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fait T. Current options of treating vulvovaginal discomfort. Med. praxi. 2019;16(4):254-256. doi: 10.36290/med.2019.039.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mašata J. Infekce v gynekologii, 2. rozšířené vydání. Maxdorf. 2014; 245 s.
    2. Líbalová Z, Čepický P. Vulvovaginitis. Mod Gynek Porod 2005; 4(14): 502-510.
    3. Čepický P. Chronické a recidivující vulvovaginitidy. Prakt Gyn 2004; 2: 8-9.
    4. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemotherapy 2006; 58: 266-272. Go to original source... Go to PubMed...
    5. Bagnall P, Rizzolo D. Bacterial vaginosis: A practical review. JAAPA. 2017; 30(12): 15-21. Go to original source... Go to PubMed...
    6. Lamont RF, Nhan-Chang CL, Sobel JD, et al. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 205(3): 177-190. Go to original source... Go to PubMed...
    7. Donders G, Vereecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002; 109(1): 34-43. Go to original source... Go to PubMed...
    8. Horowitz B, Mardh P, Nagy E, et al. Vaginal lactobacillosis. Am J Obstet Gynecol 1994, 170(3): 857-861. Go to original source... Go to PubMed...
    9. Gnann JW Jr., Whitley RJ. Clinical practice. Genital Herpes. N Engl J Med 2016; 375(7): 666-674. Go to original source... Go to PubMed...
    10. Patel R, Kennedy OJ, Clarke E, et al. 2017 European guidelines for the management of genital herpes. Int J STD AIDS 2017, 28(14): 1366-1379. Go to original source... Go to PubMed...
    11. Heine P, McGregor JA. Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol. 1993; 36(1): 137-144. Go to original source... Go to PubMed...
    12. Unzeitig V. Praktické zkušenosti s benzydaminem. Mod Gynek Porod 2001; 3(10): 382-390.
    13. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19(1): 50-62. Go to original source... Go to PubMed...
    14. Fait T. Could be Phytotherapy Implemented to Vaginal Discharge Treatment? J Adv Med Medical Res 2017; 22(6): 1-4. Go to original source...
    15. Slíva J, Minárik J. Hyaluronát - nejen pasivní pozorovatel, nýbrž aktivní modulátor imunitních reakcí. NEUMM 2009; 4(1-2): 35-38.
    16. Reid G. Therapeutic Opportunities in the Vaginal Microbiome. Microbiol Spectr 2017; 5(3). Go to original source... Go to PubMed...
    17. Myhre R, Brantsaeter AL, Myking S, et al. Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr. 2011; 93(1): 151-157. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.